Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Title||A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)|
|Recruitment||Active, not recruiting|
|Sponsors||Eli Lilly and Company|
|Age Groups:||adult | senior|
|Covered Countries||USA | ITA | FRA | ESP | DEU | CAN|